Enables mass-production (up to 1.5MM units per day) of tablets, film, implants, transdermal patches with novel drug formulations, galenic and novel geometric structures
Cold-pressure process, enables wide range of API`s
Printing speeds significantly faster than for established 3D printing processes
Innovation of improved drug delivery for established APIs generates opportunities for new patents on improved DDS
Company operates its application lab and ordered its first 3D production unit capable of mass production under GMP (Good Manufacturing Practice).